Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Bendamustine Metastatic Malignant Solid Neoplasm	Fred Hutchinson Cancer Center	P1	CC (42)
Zofran Metastatic Cancer	Fred Hutchinson Cancer Center	P1	CC (42)
Autologous Mesothelin-Specific Tcr-T Cells Pancreatic Ductal Adenocarcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
Bendamustine Pancreatic Ductal Adenocarcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
CARMUSTINE Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Fred Hutchinson Cancer Center	P1	CC (41)
CARMUSTINE High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit	Fred Hutchinson Cancer Center	P1	CC (41)
CARMUSTINE Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1	CC (41)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Childhood Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (41)
Evomela Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Fred Hutchinson Cancer Center	P1	CC (41)
Evomela High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit	Fred Hutchinson Cancer Center	P1	CC (41)
Evomela Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1	CC (41)
FILGRASTIM Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Fred Hutchinson Cancer Center	P1	CC (41)
FILGRASTIM Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Fred Hutchinson Cancer Center	P1	CC (41)
FILGRASTIM Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1	CC (41)
Fludarabine Prostate Carcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
Folr1 Car T-Cells Childhood Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (41)
Loncastuximab Tesirine Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Fred Hutchinson Cancer Center	P1	CC (41)
Loncastuximab Tesirine High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit	Fred Hutchinson Cancer Center	P1	CC (41)
Loncastuximab Tesirine Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1	CC (41)
PANTOPRAZOLE Prostate Carcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
Rimiducid Chronic Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (41)
Sotrovimab Cancer	Fred Hutchinson Cancer Center	P1	CC (41)
Zofran Metastatic Pancreatic Ductal Adenocarcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
Zofran Prostate Carcinoma	Fred Hutchinson Cancer Center	P1	CC (41)
BROMAZEPAM Prostate Small Cell Neuroendocrine Carcinoma	Fred Hutchinson Cancer Center	P1	CC (40)

Showing 526 to 550 of 567 assets

PreviousPage 22 of 23Next